JENNA VAUGHAN: Open Payments
NPI 1407564248 · NEW BRITAIN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 15 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $166 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $82 |
| Novo Nordisk Inc | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Lilly USA, LLC | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| ABBVIE INC. | 1 | $21 |
Products named: MOUNJARO, Ozempic, AIRSUPRA, VYNDAMAX, TRELEGY ELLIPTA, NURTEC ODT, VRAYLAR, Rybelsus.
Industry payments across PA — which companies pay providers there.
